Your shopping cart is empty!

Celloxy - Intermittent Hypoxic Trerapy

Availability:out of stock 0 item(s)

Product Code:

The CellOxy® device reprograms cellular metabolism through Intermittent Hypoxia-Hyperoxia Therapy (IHHT). Mitochondria respond to available oxygen levels, adjusting by increasing oxygen transporters in low oxygen conditions and decreasing them when oxygen is abundant. IHHT eliminates "old" mitochondria and accelerates the growth of new ones by alternating therapeutic hypoxia (16% to 9% O₂) and hyperoxia (up to 36% O₂) at intervals under normal atmospheric pressure.

Applications:

Enhancement of the immune system
Anti-aging
Improvement of the cardiorespiratory system
Reactivation of fat-burning capability
Improvement of the respiratory system
Changes in blood biochemistry

More Energy – More Vitality

Our bodies consist of trillions of cells, each requiring the right amount of energy for a healthier life. Every action demands energy from your cells. Over time, it may become more challenging for your body to produce the necessary energy to perform optimally. CellOxy® is designed to enhance energy efficiency, performance, and recovery, helping you lead a fuller life.

Healthy Mitochondria Enhance Quality of Life

Our bodies are equipped to metabolize food, eliminate waste, and combat inflammation. These processes involve a balance of oxidative and antioxidative states, originating from our energy production centers, the mitochondria. When mitochondria malfunction, it disrupts the control of free radical production and destruction, leading to cellular and tissue damage, aging, and disease. CellOxy® provides the necessary "breaths" for mitochondria to shed excess burdens and function at 100%.

Therapy Procedure:

The user sits comfortably in a chair, breathing hypoxic (reduced O₂) and hyperoxic (enriched O₂) air at individually determined intervals through a breathing mask. Data collected during the therapy are displayed on the computer screen and continuously recorded for documentation and analysis.

Unique Features:

Optimal O₂ Level Determination: After setting the ideal SpO₂ value for the hypoxia phase, the hypoxic test is performed in fully automated mode. The patient breathes the air mixture, and at the end of the test, the device stores the value.
Real-time RMSSD Measurements: After saving the test, measurable parameters are calculated and stored.
Resistance Type Determination: This crucial test warns of potential complications during therapy, preventing the possibility of Acute Mountain Sickness (AMS) during treatment. The result also helps define the optimal O₂ reduction rate during therapy.
Hypoxic Index Calculation: The software automatically calculates the hypoxic index for each session, storing values and plotting them over time to visualize adaptation to hypoxic therapy.
Reoxygenation Phase Optimization: Using intelligent reoxygenation settings, the system switches from hyperoxia to normoxia once saturation returns to pre-hypoxia levels.

Hypoxia affects the human body and induces changes impacting health. The CellOxy® device has a medical CE certification and complies with all EU regulations, quality, and legal requirements.